Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma.
Michot JM, Buet-Elfassy A, Annereau M, Lazarovici J, Danu A, Sarkozy C, Chahine C, Bigenwald C, Bosq J, Rossignol J, Romano-Martin P, Baldini C, Ghez D, Dartigues P, Massard C, Ribrag V.
Michot JM, et al. Among authors: bosq j.
Cancer Drug Resist. 2021 Mar 26;4(3):710-718. doi: 10.20517/cdr.2020.109. eCollection 2021.
Cancer Drug Resist. 2021.
PMID: 35582306
Free PMC article.